FDA sends warning letter to Novo Nordisk over failure to report deaths, adverse side effects of GLP-1s
The U.S. Food and Drug Administration (FDA) has issued a warning to Novo Nordisk over its alleged failure to report...
Read more
The U.S. Food and Drug Administration (FDA) has issued a warning to Novo Nordisk over its alleged failure to report...
Read more
